Product Dossier
APO-OLMESARTAN/AMLODIPINE/HCTZ
Product Dossier for APO-OLMESARTAN/AMLODIPINE/HCTZ (amlodipine besilate, Arrotex Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by…
- Sponsor: Arrotex Pharmaceuticals
- Active ingredient: amlodipine besilate
- Therapeutic area: Cardiology
- Related brand: AMLODIPINE-WGR
- Related brand: CADUET
- Related brand: EXFORGE
- Same area: LONITEN
- Same area: XYLOCARD
I cannot write a
Brand Dossier for APO-OLMESARTAN/AMLODIPINE/HCTZ based on the provided documents.
The documents supplied contain: 1. Product information for AMLODIPINE/VALSARTAN/HCTZ (a different triple-combination medicine) 2. ARTG registration records confirming that APO-OLMESARTAN/AMLODIPINE/HCTZ contains olmesartan medoxomil (not valsartan)
These documents are incompatible. The detailed clinical information in Document 1 pertains to a valsartan-based combination and cannot be accurately cited for an olmesartan-based product, as the active ingredients, indications, dosing, safety profiles and contraindications differ between angiotensin II receptor blockers.
To produce an accurate and properly cited Brand Dossier for APO-OLMESARTAN/AMLODIPINE/HCTZ, I would require source documents specific to that medicine—such as its product information sheet, PBAC submissions, AusPAR, or PBS listing details.